134 related articles for article (PubMed ID: 35421639)
21. Criterion validity of muscle strain analyses of skeletal muscle function in patients with multiple sclerosis.
Thorning M; Lambertsen KL; Skov CD; Frich LH; Jensen HB; Holsgaard-Larsen A; Nielsen HH
Mult Scler Relat Disord; 2023 Feb; 70():104478. PubMed ID: 36603294
[TBL] [Abstract][Full Text] [Related]
22. The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis.
Cadavid D; Cohen JA; Freedman MS; Goldman MD; Hartung HP; Havrdova E; Jeffery D; Kapoor R; Miller A; Sellebjerg F; Kinch D; Lee S; Shang S; Mikol D
Mult Scler; 2017 Jan; 23(1):94-105. PubMed ID: 27003945
[TBL] [Abstract][Full Text] [Related]
23. Validation of the Brazilian version of the patient-determined disease steps scale in persons with multiple sclerosis.
de David AC; Sasaki JE; Ramari C; Tauil CB; Moraes AG; Martins F; von Glehn F; Motl RW
Mult Scler Relat Disord; 2019 May; 30():208-214. PubMed ID: 30818129
[TBL] [Abstract][Full Text] [Related]
24. Do evoked potentials contribute to the functional follow-up and clinical prognosis of multiple sclerosis?
Giffroy X; Maes N; Albert A; Maquet P; Crielaard JM; Dive D
Acta Neurol Belg; 2017 Mar; 117(1):53-59. PubMed ID: 27194163
[TBL] [Abstract][Full Text] [Related]
25. A 3meter Timed Tandem Walk is an early marker of motor and cerebellar impairment in fully ambulatory MS patients.
Stellmann JP; Vettorazzi E; Poettgen J; Heesen C
J Neurol Sci; 2014 Nov; 346(1-2):99-106. PubMed ID: 25156343
[TBL] [Abstract][Full Text] [Related]
26. Motor assessment of upper extremity function and its relation with fatigue, cognitive function and quality of life in multiple sclerosis patients.
Yozbatiran N; Baskurt F; Baskurt Z; Ozakbas S; Idiman E
J Neurol Sci; 2006 Jul; 246(1-2):117-22. PubMed ID: 16678208
[TBL] [Abstract][Full Text] [Related]
27. Does disability level impact the relationship of muscle strength to walking performance in people with multiple sclerosis? a cross-sectional analysis.
Mañago MM; Callesen J; Dalgas U; Kittelson J; Schenkman M
Mult Scler Relat Disord; 2020 Jul; 42():102052. PubMed ID: 32240963
[TBL] [Abstract][Full Text] [Related]
28. Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon-beta-1a.
Jongen PJ; Sindic C; Carton H; Zwanikken C; Lemmens W; Borm G;
J Neurol; 2010 Apr; 257(4):584-9. PubMed ID: 19921303
[TBL] [Abstract][Full Text] [Related]
29. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
Pavsic K; Pelicon K; Ledinek AH; Sega S
Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome measures for research in multiple sclerosis.
Balcer LJ
J Neuroophthalmol; 2001 Dec; 21(4):296-301. PubMed ID: 11756863
[TBL] [Abstract][Full Text] [Related]
31. Utility of the Six-Spot Step Test as a Measure of Walking Performance in Ambulatory Individuals With Multiple Sclerosis.
Fritz NE; Jiang A; Keller J; Zackowski KM
Arch Phys Med Rehabil; 2016 Apr; 97(4):507-512. PubMed ID: 26577146
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life.
Miller DM; Rudick RA; Cutter G; Baier M; Fischer JS
Arch Neurol; 2000 Sep; 57(9):1319-24. PubMed ID: 10987899
[TBL] [Abstract][Full Text] [Related]
33. Erratum.
Mult Scler; 2016 Oct; 22(12):NP9-NP11. PubMed ID: 26041800
[TBL] [Abstract][Full Text] [Related]
34. [Application of the Multiple Sclerosis Functional Composite in Debrecen].
Mezei Z; Bereczki D; Csiba L; Csépány T
Ideggyogy Sz; 2005 Mar; 58(3-4):113-8. PubMed ID: 15887414
[TBL] [Abstract][Full Text] [Related]
35. Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies.
Hernandez L; O'Donnell M; Postma M;
Pharmacoeconomics; 2021 Feb; 39(2):243-256. PubMed ID: 32989685
[TBL] [Abstract][Full Text] [Related]
36. Clinical assessment of gait in individuals with multiple sclerosis using wearable inertial sensors: Comparison with patient-based measure.
Pau M; Caggiari S; Mura A; Corona F; Leban B; Coghe G; Lorefice L; Marrosu MG; Cocco E
Mult Scler Relat Disord; 2016 Nov; 10():187-191. PubMed ID: 27919488
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcome measures in SPMS trials: An analysis of the IMPACT and ASCEND original trial data sets.
Koch MW; Mostert J; Uitdehaag B; Cutter G
Mult Scler; 2020 Oct; 26(12):1540-1549. PubMed ID: 31517591
[TBL] [Abstract][Full Text] [Related]
38. [Long-term application of the multiple sclerosis functional composite test in Debrecen, Hungary].
Mezei Z; Bereczki D; Csiba L; Csépány T
Ideggyogy Sz; 2006 Nov; 59(11-12):442-7. PubMed ID: 17203882
[TBL] [Abstract][Full Text] [Related]
39. [The Expanded Disability Status Scale scoring in patients with multiple sclerosis].
Füvesi J
Ideggyogy Sz; 2019 Sep; 72(9-10):317-323. PubMed ID: 31625698
[TBL] [Abstract][Full Text] [Related]
40. Correlations between multiple sclerosis functional composite, expanded disability status scale and health-related quality of life during and after treatment of relapses in patients with multiple sclerosis.
Ozakbas S; Cagiran I; Ormeci B; Idiman E
J Neurol Sci; 2004 Mar; 218(1-2):3-7. PubMed ID: 14759626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
